Amsacrine analog-loaded solid lipid nanoparticle to resolve insolubility for injection delivery: characterization and pharmacokinetics

References

• ArlinZAFeldmanEKempinSAmsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adultsBlood1988724334353165293
   PubMed Web of Science ®Google Scholar
• LeghaSSKeatingMJMcCredieKBBodeyGPFreireichEJEvaluation of AMSA in previously treated patients with acute leukemia results of therapy in 109 adultsBlood1982604844906953987
   PubMed Web of Science ®Google Scholar
• JehnUHeinemannVNew drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSAAnticancer Res1991117057112064323
   PubMed Web of Science ®Google Scholar
• FenauxPTertianGCastaigneSA randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemiaJ Clin Oncol19919155615611805818
   PubMed Web of Science ®Google Scholar
• PaxtonJWKimSNWhitfieldLRPharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humansCancer Res199050269226972328494
   PubMed Web of Science ®Google Scholar
• ChenILChenYLTzengCCChenISSynthesis and cytotoxic evaluation of some 4-anilinofuro[2,3-b]quinoline derivativesHelv Chim Acta20028522142221
   Web of Science ®Google Scholar
• FinlayGJRiouJFBaguleyBCFrom amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivativesEur J Cancer199632A7087148695277
   PubMed Web of Science ®Google Scholar
• ChenYLChenILWangTCHanCHTzengCCSynthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivativesEur J Med Chem20054092893415913847
   PubMed Web of Science ®Google Scholar
• DesaiALeeMGibaldi’s Drug Delivery Systems in Pharmaceutical CareBethesda, MarylandAmerican Society of Health-System Pharmacist2007111
   Google Scholar
• TammamSNAzzazyHMLamprechtABiodegradable particulate carrier formulation and tuning for targeted drug deliveryJ Biomed Nanotechnol20151155557726310064
   PubMed Web of Science ®Google Scholar
• YohanDChithraniBDApplications of nanoparticles in nanomedicineJ Biomed Nanotechnol2014102371239225992462
   PubMed Web of Science ®Google Scholar
• LiJWangYLiangRRecent advances in targeted nanoparticles drug delivery to melanomaNanomedicine20151176979425555352
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254Suppl 1S131S15512460720
   PubMed Web of Science ®Google Scholar
• Ezzati Nazhad DolatabadiJValizadehHHamishehkarHSolid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughsAdv Pharm Bull2015515115926236652
   PubMed Web of Science ®Google Scholar
• KambojSBalaSNairABSolid lipid nanoparticles: an effective lipid based technology for poorly water soluble drugsInt J Pharm Sci Rev Res201057890
   Google Scholar
• KankeMSimmonsGHWeissDLBivinsBADeLucaPPClearance of 141C3-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogsJ Pharm Sci1980697557627391933
   PubMed Web of Science ®Google Scholar
• WiedemanMPDimensions of blood vessels from distributing artery to collecting veinCirc Res19631237537814000509
   PubMed Web of Science ®Google Scholar
• KosteraVSKuksPFLangeRTalsmaHParticle size in parenteral fat emulsions, what are the true limitations?Int J Pharm1996134235238
   Web of Science ®Google Scholar
• NairRArun KumarKSVishnu PriyaKSevukarajanMRecent advances in solid lipid nanoparticle based drug delivery systemsJ Biomed Sci Res20113368384
   Google Scholar
• KumarVVChandrasekarDRamakrishnaSKishanVRaoYMDiwanPVDevelopment and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokineticsInt J Pharm200733516717517161566
   PubMed Web of Science ®Google Scholar
• DoktorovovaSShegokarRRakovskyECationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studiesInt J Pharm201142034134921907778
   PubMed Web of Science ®Google Scholar
• FritzGSchädlerVWillenbacherNWagnerNJElectrosteric stabilization of colloidal dispersionsLangmuir20021863816390
   Web of Science ®Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm20005016117710840199
   PubMed Web of Science ®Google Scholar
• FuYKaoWJDrug release kinetics and transport mechanism of non-degradable and degradable polymeric delivery systemExpert Opin Drug Deliv2010742944420331353
   PubMed Web of Science ®Google Scholar
• SinghviGSinghMReview: in-vitro drug release characterization modelsInt J Pharm Studies Res201127784
   Google Scholar
• GrassiMGrassiGMathematical modeling and controlled drug delivery: matrix systemCurrent Drug Deliv2005297116
   PubMedGoogle Scholar
• NunthanidJHuanbuttaKLuangtana-ananMSriamornsakPLimmatvapiratSPuttipipatkhachornSDevelopment of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcelluloseEur J Pharm Biopharm20086825325917616377
   PubMed Web of Science ®Google Scholar
• FangYPWuPCTzengCCChenYLLinHLTsaiYHA new antitumor agent, (3-chloro-7-methoxyfuro[2,3-b]-quinolin-4-yl)-(4-methoxyphenyl)amine, loaded in solid lipid nanoparticles: characterization and pharmacokineticsCurr Nanosci20128266273
   Web of Science ®Google Scholar
• FangYPWuPCHuangYBModification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection deliveryInt J Nanomedicine201274995500523055719
   PubMed Web of Science ®Google Scholar
• EkambaramPAbdul Hasan SathaliAPriyankaKSolid lipid nanoparticles – a reviewInt J App Pharm20135818
   Google Scholar
• LiuMLiHLuoGLiuQWangYPharmacokinetics and biodistribution of surface modification polymeric nanoparticlesArch Pharm Res20083154755418449515
   PubMed Web of Science ®Google Scholar
• ManjunathKVenkateswarluVPharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administrationJ Control Release200510721522816014318
   PubMed Web of Science ®Google Scholar
• Harivardhan ReddyLSharmaRKChuttaniKMishraAKMurthyRSInfluence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing miceJ Control Release200510518519815921775
   PubMed Web of Science ®Google Scholar
• BagulRMahajanVDhakenewANew approaches in nanoparticulate drug delivery system – a reviewInt J Curr Pharm Res201242938
   Google Scholar